Adiposity, depression and anxiety: interrelationship and possible mediators

Detalhes bibliográficos
Autor(a) principal: Gomes, Ana Paula
Data de Publicação: 2019
Outros Autores: Soares, Ana Luiza G., Menezes, Ana M.B., Assunção, Maria Cecília, Wehrmeister, Fernando C., Howe, Laura D., Gonçalves, Helen
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista de Saúde Pública
Texto Completo: https://www.revistas.usp.br/rsp/article/view/164354
Resumo: OBJECTIVES: To explore the association between adiposity, major depressive disorder and generalized anxiety disorder, and to assess the role of inflammation, diet quality and physical activity in this association. METHODS: We used data from 2,977 individuals from the 1993 Pelotas Cohort (Brazil) who attended the 18- and 22-year follow-ups. We assessed general obesity using body mass index, fat mass index, and abdominal obesity using waist circumference. Major Depressive Disorder and generalized anxiety disorder were assessed using the mini-international neuropsychiatric interview. C-reactive protein and interleukin-6 (IL-6) levels were used as a measure of inflammation; diet quality was estimated using the revised diet quality index, and physical activity was assessed by the International physical activity questionnaire (IPAQ, min/day). The association between adiposity and major depressive disorder and generalized anxiety disorder was assessed using logistic regression, and the natural indirect effect via the mediators was estimated using G-computation. RESULTS: General obesity assessed by body mass index (OR: 2.3; 95% CI:1.13; 4.85), fat mass index (OR: 2.6; 95%CI: 1.37; 4.83), and abdominal obesity (OR: 2.5; 95%CI: 1.18; 5.39) were associated with higher odds of major depressive disorder, whereas major depressive disorder was only associated with obesity assessed by body mass index (OR=1.9; 95% CI: 1.09; 3.46). Obesity and generalized anxiety disorder were not associated. C-reactive protein, diet quality and physical activity did not mediate the effect of obesity on major depressive disorder, and C-reactive protein mediated about 25% of the effect of major depressive disorder on adiposity. CONCLUSIONS: Depression, but not generalized anxiety disorder, is associated with adiposity in both directions, with a stronger evidence for the direction obesity-depression. Inflammation explains part of the effect of major depressive disorder on obesity but not the other way around. Further research should explore other mechanisms that could be involved in the association between obesity and depression.
id USP-23_b07da33f37254b4ecbe20bb24d9c59b1
oai_identifier_str oai:revistas.usp.br:article/164354
network_acronym_str USP-23
network_name_str Revista de Saúde Pública
repository_id_str
spelling Adiposity, depression and anxiety: interrelationship and possible mediatorsAdiposityObesityDepressionAnxiety DisordersMeasures of Association, Exposure, Risk or OutcomeOBJECTIVES: To explore the association between adiposity, major depressive disorder and generalized anxiety disorder, and to assess the role of inflammation, diet quality and physical activity in this association. METHODS: We used data from 2,977 individuals from the 1993 Pelotas Cohort (Brazil) who attended the 18- and 22-year follow-ups. We assessed general obesity using body mass index, fat mass index, and abdominal obesity using waist circumference. Major Depressive Disorder and generalized anxiety disorder were assessed using the mini-international neuropsychiatric interview. C-reactive protein and interleukin-6 (IL-6) levels were used as a measure of inflammation; diet quality was estimated using the revised diet quality index, and physical activity was assessed by the International physical activity questionnaire (IPAQ, min/day). The association between adiposity and major depressive disorder and generalized anxiety disorder was assessed using logistic regression, and the natural indirect effect via the mediators was estimated using G-computation. RESULTS: General obesity assessed by body mass index (OR: 2.3; 95% CI:1.13; 4.85), fat mass index (OR: 2.6; 95%CI: 1.37; 4.83), and abdominal obesity (OR: 2.5; 95%CI: 1.18; 5.39) were associated with higher odds of major depressive disorder, whereas major depressive disorder was only associated with obesity assessed by body mass index (OR=1.9; 95% CI: 1.09; 3.46). Obesity and generalized anxiety disorder were not associated. C-reactive protein, diet quality and physical activity did not mediate the effect of obesity on major depressive disorder, and C-reactive protein mediated about 25% of the effect of major depressive disorder on adiposity. CONCLUSIONS: Depression, but not generalized anxiety disorder, is associated with adiposity in both directions, with a stronger evidence for the direction obesity-depression. Inflammation explains part of the effect of major depressive disorder on obesity but not the other way around. Further research should explore other mechanisms that could be involved in the association between obesity and depression.Universidade de São Paulo. Faculdade de Saúde Pública2019-11-22info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/xmlhttps://www.revistas.usp.br/rsp/article/view/16435410.11606/S1518-8787.2019053001119Revista de Saúde Pública; Vol. 53 (2019); 103Revista de Saúde Pública; Vol. 53 (2019); 103Revista de Saúde Pública; v. 53 (2019); 1031518-87870034-8910reponame:Revista de Saúde Públicainstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/rsp/article/view/164354/157650https://www.revistas.usp.br/rsp/article/view/164354/157651Copyright (c) 2019 Revista de Saúde Públicainfo:eu-repo/semantics/openAccessGomes, Ana PaulaSoares, Ana Luiza G.Menezes, Ana M.B.Assunção, Maria CecíliaWehrmeister, Fernando C.Howe, Laura D.Gonçalves, Helen2019-12-10T12:07:05Zoai:revistas.usp.br:article/164354Revistahttps://www.revistas.usp.br/rsp/indexONGhttps://www.revistas.usp.br/rsp/oairevsp@org.usp.br||revsp1@usp.br1518-87870034-8910opendoar:2019-12-10T12:07:05Revista de Saúde Pública - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Adiposity, depression and anxiety: interrelationship and possible mediators
title Adiposity, depression and anxiety: interrelationship and possible mediators
spellingShingle Adiposity, depression and anxiety: interrelationship and possible mediators
Gomes, Ana Paula
Adiposity
Obesity
Depression
Anxiety Disorders
Measures of Association, Exposure, Risk or Outcome
title_short Adiposity, depression and anxiety: interrelationship and possible mediators
title_full Adiposity, depression and anxiety: interrelationship and possible mediators
title_fullStr Adiposity, depression and anxiety: interrelationship and possible mediators
title_full_unstemmed Adiposity, depression and anxiety: interrelationship and possible mediators
title_sort Adiposity, depression and anxiety: interrelationship and possible mediators
author Gomes, Ana Paula
author_facet Gomes, Ana Paula
Soares, Ana Luiza G.
Menezes, Ana M.B.
Assunção, Maria Cecília
Wehrmeister, Fernando C.
Howe, Laura D.
Gonçalves, Helen
author_role author
author2 Soares, Ana Luiza G.
Menezes, Ana M.B.
Assunção, Maria Cecília
Wehrmeister, Fernando C.
Howe, Laura D.
Gonçalves, Helen
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Gomes, Ana Paula
Soares, Ana Luiza G.
Menezes, Ana M.B.
Assunção, Maria Cecília
Wehrmeister, Fernando C.
Howe, Laura D.
Gonçalves, Helen
dc.subject.por.fl_str_mv Adiposity
Obesity
Depression
Anxiety Disorders
Measures of Association, Exposure, Risk or Outcome
topic Adiposity
Obesity
Depression
Anxiety Disorders
Measures of Association, Exposure, Risk or Outcome
description OBJECTIVES: To explore the association between adiposity, major depressive disorder and generalized anxiety disorder, and to assess the role of inflammation, diet quality and physical activity in this association. METHODS: We used data from 2,977 individuals from the 1993 Pelotas Cohort (Brazil) who attended the 18- and 22-year follow-ups. We assessed general obesity using body mass index, fat mass index, and abdominal obesity using waist circumference. Major Depressive Disorder and generalized anxiety disorder were assessed using the mini-international neuropsychiatric interview. C-reactive protein and interleukin-6 (IL-6) levels were used as a measure of inflammation; diet quality was estimated using the revised diet quality index, and physical activity was assessed by the International physical activity questionnaire (IPAQ, min/day). The association between adiposity and major depressive disorder and generalized anxiety disorder was assessed using logistic regression, and the natural indirect effect via the mediators was estimated using G-computation. RESULTS: General obesity assessed by body mass index (OR: 2.3; 95% CI:1.13; 4.85), fat mass index (OR: 2.6; 95%CI: 1.37; 4.83), and abdominal obesity (OR: 2.5; 95%CI: 1.18; 5.39) were associated with higher odds of major depressive disorder, whereas major depressive disorder was only associated with obesity assessed by body mass index (OR=1.9; 95% CI: 1.09; 3.46). Obesity and generalized anxiety disorder were not associated. C-reactive protein, diet quality and physical activity did not mediate the effect of obesity on major depressive disorder, and C-reactive protein mediated about 25% of the effect of major depressive disorder on adiposity. CONCLUSIONS: Depression, but not generalized anxiety disorder, is associated with adiposity in both directions, with a stronger evidence for the direction obesity-depression. Inflammation explains part of the effect of major depressive disorder on obesity but not the other way around. Further research should explore other mechanisms that could be involved in the association between obesity and depression.
publishDate 2019
dc.date.none.fl_str_mv 2019-11-22
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/rsp/article/view/164354
10.11606/S1518-8787.2019053001119
url https://www.revistas.usp.br/rsp/article/view/164354
identifier_str_mv 10.11606/S1518-8787.2019053001119
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/rsp/article/view/164354/157650
https://www.revistas.usp.br/rsp/article/view/164354/157651
dc.rights.driver.fl_str_mv Copyright (c) 2019 Revista de Saúde Pública
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2019 Revista de Saúde Pública
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/xml
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Saúde Pública
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Saúde Pública
dc.source.none.fl_str_mv Revista de Saúde Pública; Vol. 53 (2019); 103
Revista de Saúde Pública; Vol. 53 (2019); 103
Revista de Saúde Pública; v. 53 (2019); 103
1518-8787
0034-8910
reponame:Revista de Saúde Pública
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Revista de Saúde Pública
collection Revista de Saúde Pública
repository.name.fl_str_mv Revista de Saúde Pública - Universidade de São Paulo (USP)
repository.mail.fl_str_mv revsp@org.usp.br||revsp1@usp.br
_version_ 1787713239908352000